findmyKOL
Clinical trialNCT02141308RecruitingObservational

OCT in Rare Chorioretinal Diseases

SponsorOregon Health and Science UniversityEnrollment150Central Serous ChorioretinopathyJuxtafoveal TelangiecasiaPolypoidal Choroidal VasculopathyRetinal Arterial MacroaneurysmRetinal Artery Occlusions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will evaluate the total blood flow in the retina and choroid (structures in the back of the eye) by Doppler optical coherence tomography (OCT) and OCT angiography. Angiography is mapping of the blood vessels. The purpose of measuring blood flow in the retina and choroid is to 1.) determine if rare diseases in these structures causes a change in blood flow compared to healthy eyes and 2.) find out if areas of changed blood flow line up with areas of damage that appear on conventional testing.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Casey Eye Institute, Oregon Health & Science University

    Portland, Oregon, United States

    Andreas Lauer, MDChristina Flaxel, MDDavid Huang, MD, PhDEric Suhler, MDJohn Campbell, MD, MPHMichael Klein, MDSteven Bailey, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2014
Primary completion
31 Dec 2025
Completion
31 Dec 2026
Last update posted
12 Feb 2024
Registered enrollment
150
Registry id
NCT02141308
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.